Latest News about BIIB
Recent news which mentions BIIB
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More
September 25, 2021
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
September 23, 2021
Tickers
BIIB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
Thinking About Buying Stock Or Options In Tesla, Ballard Power, Bloom Energy Or Biogen?
September 23, 2021
From Benzinga
From Benzinga
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
From Motley Fool
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Biogen Reports Mixed Phase 2 Data For Its Non-Opioid Pain Candidate
September 16, 2021
Tickers
BIIB
From Benzinga
Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
September 15, 2021
From Benzinga
3 Quality Stocks to Buy From the Bargain Bin
September 13, 2021
From InvestorPlace
Cassava Stock Is a Bold Play That Could Pay Off Soon
September 13, 2021
From InvestorPlace
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
Why Biogen Stock Is Sinking This Week
September 10, 2021
From Motley Fool
Why Biogen Stock Is Slipping Today
September 09, 2021
From Motley Fool
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy
September 09, 2021
From InvestorPlace
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
Better Buy: Biogen vs. Cassava Sciences
September 04, 2021
From Motley Fool
Congress Asks For Approval Documents Of Biogen's Alzheimer's Drug: Report
September 02, 2021
Tickers
BIIB
From Benzinga
Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations
September 02, 2021
From InvestorPlace
From Benzinga
Wait to See How the Cassava Sciences Allegations Pan Out
August 31, 2021
From InvestorPlace
From Benzinga
Biogen: What to Do When Your Investment Thesis Is Disproven
August 29, 2021
Tickers
BIIB
From Motley Fool
Why the Cassava Sciences Bears Are Wrong
August 27, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
